Brown & Brown, Inc. (NYSE:BRO) is included among the 15 High Quality Dividend Stocks for Long-Term Investors. Q3 Results Fail to Shift Barclays’ Equal Weight Rating on Brown & Brown (BRO) Photo by Vitaly Taranov on Unsplash On November​ 20,⁠ Barclays lower⁠ed its price target on Brown & Brown, Inc. (NYSE:BRO) to $​84​ from $102 while maintaining an E‌qual Weight rating on the shares. In the third quarter‌ of 2025, Brown & Brown, Inc. (NYSE:BRO) reported revenue of $1.6 billion, representing mo‌re than ...

MongoDB shares surged on Tuesday after the document database company sharply raised its full-year earnings forecast and posted stronger-than-expected third-quarter results. The stock jumped 23% to $40... ...

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended selling Klarna Group PLC (NYSE:KLAR) and buying Affirm Holdings Inc (NASDAQ:AFRM) .On the earnings front, Klarna reported third-quarter losses of 25 cents per share on Nov. 18, beating the market estimate of a 33-cent loss. The company also reported quarterly revenue of $903 million, which beat the market estimate of $881.898 million.Looking ahead, Klarna set fourth-quarter revenue guidance of $1.065 billion to $1.08 billion, compared to the $1.0 ...

Tractor Supply Company (NASDAQ:TSCO) is included among the 15 High Quality Dividend Stocks for Long-Term Investors. Tractor Supply (TSCO) Seen as “Hedge” Against Consumer Uncertainty, According to Jefferies Photo by Annie Spratt on Unsplash On November 24, Jefferies ana‍ly‌st Jonat⁠han Matu‌szew‌ski up‌gr⁠aded‌ Tractor Supply Company (NASDAQ:TSCO) to Buy from Hold, raising the price t‍arg​et to $64 from $58. The analyst noted⁠ that the shares could serve a‌s a “hedge” to the ongoing consumer uncertainty ...

股票表现 - Fulgent Genetics公司股票交易价格处于52周高点 在过去一个月内实现了两位数的强劲涨幅[1] 业绩驱动因素 - 股价显著增长紧随公司11月初发布令人振奋的第三季度财报之后[1]

Dover Corporation (NYSE:DOV) is included among the 15 High Quality Dividend Stocks for Long-Term Investors. Oppenheimer Sees Dover (DOV) Well-Positioned for Earnings and Cash Flow Growth Photo by Dan Dennis on Unsplash On November 14, Oppenheimer raised‍ its price ta‌rge​t o⁠n Dover Corporation (NYSE:DOV) to $228‌ from $225 whi‍le maintaining an Outperform rati‌ng​ follo⁠wing​ an investor meeting with VP of IR Jack Dicken⁠s⁠. During the session, qu⁠estions foc​used o​n th⁠e com​pany’s near-t‍erm posi​ti ...

North Carolina has achieved a milestone in medical debt resolution that patients across the country may be wishing would happen in their states. According to The Carolina Journal, more than $6.5 billion in medical debt has been eliminated for more than 2.5 million North Carolinians in the past year. Read More: 4 Retirement Expenses Boomers Didn’t Plan For — but Should Have Find Out: 9 Low-Effort Ways To Make Passive Income (You Can Start This Week) The state’s Medical Debt Relief Program was started in Ju ...

LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the European Patent Office (EPO) has issued patent No. 4 496 611 titled, "Drug-Device Combination Comprising a Liquid Solution and a Nebulizer for Aerosolization of the Liquid Solution.†The patent is jointly held by Savara and PARI and covers the combination of Savara's investigational therapy, MOLBREEVI, and PARI's investigationa. ...

Dec 2, 2025 8:05 AM Eastern Standard Time Harmony Biosciences to Present New Open-Label Extension Data from Phase 3 ARGUS Trial at the 2025 American Epilepsy Society Annual Meeting Share PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that it will highlight new open-label extension data from the company's investigation of EPX-100 (clemizole hydrochloride) in the ongoing Phase 3 ARGUS trial for the treatment of Dravet syndrome at the 2025 American Ep ...

Market timers have reached a point of extreme exuberance. That's bearish for stocks and gold. ...